Literature DB >> 15026579

Promiscuity rules? The dispensability of cyclin E and Cdk2.

Tin Tin Su1, Jason Stumpff.   

Abstract

The canonical view of the mammalian cell cycle arose from studies of cultured cells rather than mutant organisms. It depicts the many complexes of cyclin and Cdk (cyclin/Cdk) as fulfilling unique and essential steps that dictate the sequential order of cell cycle events. Recent analyses of knockout mice challenge this view. Cdk2 and cyclin E, long thought to be essential, are largely dispensable. Here, we discuss the phenotypes of these and other cyclin/Cdk mutants in genetically tractable metazoa (mouse, fly, and nematode) and explore possible reasons behind similarities and differences among experimental systems and cell types.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026579      PMCID: PMC3242733          DOI: 10.1126/stke.2242004pe11

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  28 in total

1.  Cyclin E ablation in the mouse.

Authors:  Yan Geng; Qunyan Yu; Ewa Sicinska; Manjusri Das; Jürgen E Schneider; Shoumo Bhattacharya; William M Rideout; Roderick T Bronson; Humphrey Gardner; Piotr Sicinski
Journal:  Cell       Date:  2003-08-22       Impact factor: 41.582

2.  Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression.

Authors:  C A Meyer; H W Jacobs; S A Datar; W Du; B A Edgar; C F Lehner
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

3.  Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells.

Authors:  Tiziana Parisi; Andreas R Beck; Nathalie Rougier; Tom McNeil; Linda Lucian; Zena Werb; Bruno Amati
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

4.  Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation.

Authors:  J A Knoblich; K Sauer; L Jones; H Richardson; R Saint; C F Lehner
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

5.  Distinct roles for cyclin-dependent kinases in cell cycle control.

Authors:  S van den Heuvel; E Harlow
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

6.  Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice.

Authors:  Sagrario Ortega; Ignacio Prieto; Junko Odajima; Alberto Martín; Pierre Dubus; Rocio Sotillo; Jose Luis Barbero; Marcos Malumbres; Mariano Barbacid
Journal:  Nat Genet       Date:  2003-08-17       Impact factor: 38.330

Review 7.  Cyclins A and B1 in the human cell cycle.

Authors:  J Pines; T Hunter
Journal:  Ciba Found Symp       Date:  1992

8.  The cdk2 kinase is required for the G1-to-S transition in mammalian cells.

Authors:  L H Tsai; E Lees; B Faha; E Harlow; K Riabowol
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

9.  Cyclin A is required for the onset of DNA replication in mammalian fibroblasts.

Authors:  F Girard; U Strausfeld; A Fernandez; N J Lamb
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

10.  Cyclin A is required at two points in the human cell cycle.

Authors:  M Pagano; R Pepperkok; F Verde; W Ansorge; G Draetta
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  12 in total

1.  A chrysin derivative suppresses skin cancer growth by inhibiting cyclin-dependent kinases.

Authors:  Haidan Liu; Kangdong Liu; Zunnan Huang; Chan-Mi Park; N R Thimmegowda; Jae-Hyuk Jang; In-Ja Ryoo; Long He; Sun-Ok Kim; Naomi Oi; Ki Won Lee; Nak-Kyun Soung; Ann M Bode; Yifeng Yang; Xinmin Zhou; Raymond L Erikson; Jong-Seog Ahn; Joonsung Hwang; Kyoon Eon Kim; Zigang Dong; Bo-Yeon Kim
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

Review 2.  Cell cycle regulation of DNA replication.

Authors:  R A Sclafani; T M Holzen
Journal:  Annu Rev Genet       Date:  2007       Impact factor: 16.830

3.  Discovery of a distinct domain in cyclin A sufficient for centrosomal localization independently of Cdk binding.

Authors:  Gaetan Pascreau; Frank Eckerdt; Mair E A Churchill; James L Maller
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

4.  The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis.

Authors:  L van der Weyden; K K Tachibana; M A Gonzalez; D J Adams; B L Ng; R Petty; A R Venkitaraman; M J Arends; A Bradley
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer.

Authors:  C Elizabeth Caldon; Elizabeth A Musgrove
Journal:  Cell Div       Date:  2010-01-17       Impact factor: 5.130

6.  CDK2 regulation through PI3K and CDK4 is necessary for cell cycle progression of primary rat hepatocytes.

Authors:  L Wierød; C M Rosseland; B Lindeman; M P Oksvold; H Grøsvik; E Skarpen; H S Huitfeldt
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

7.  CDK-mediated regulation of cell functions via c-Jun phosphorylation and AP-1 activation.

Authors:  Tony J Vanden Bush; Gail A Bishop
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

8.  UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required for zebrafish embryogenesis.

Authors:  Jaime Chu; Elizabeth A Loughlin; Naseem A Gaur; Sucharita SenBanerjee; Vinitha Jacob; Christopher Monson; Brandon Kent; Amanke Oranu; Yuanying Ding; Chinweike Ukomadu; Kirsten C Sadler
Journal:  Mol Biol Cell       Date:  2011-11-09       Impact factor: 4.138

9.  CDK4 regulation by TNFR1 and JNK is required for NF-kappaB-mediated epidermal growth control.

Authors:  Jennifer Y Zhang; Shiying Tao; Robin Kimmel; Paul A Khavari
Journal:  J Cell Biol       Date:  2005-02-07       Impact factor: 10.539

10.  Expression of cell cycle regulators during smooth muscle cell proliferation after balloon catheter injury of rat artery.

Authors:  Jung Kee Chung; Taeseung Lee; In Mok Jung; Young Kyun Kim; Seung Kee Min; Jeong Wook Suh; Sang Joon Kim
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.